Gergely Hetényi1, Janine Griesser1, Isabelle Nardin1, Andreas Bernkop-Schnürch2,3. 1. Thiomatrix Forschungs-und Beratungs GmbH,, Innsbruck, Austria. 2. Thiomatrix Forschungs-und Beratungs GmbH,, Innsbruck, Austria. andreas.bernkop@uibk.ac.at. 3. Department of Pharmaceutical Technology, Center for Chemistry and Biomedicine, Institute of Pharmacy, Leopold-Franzens-University, Innrain 80/82, 6020, Innsbruck, Austria. andreas.bernkop@uibk.ac.at.
Abstract
PURPOSE: The aim of the study was to create novel mucoadhesive drug delivery systems by incorporating amphiphilic hydrophobically modified, thiolated and preactivated polymers (preactivated thiomers) into self-emulsifying drug delivery systems (SEDDS). METHODS: L-Cysteine methyl ester was covalently attached to the polymeric backbone of Pemulen TR-2 and preactivated using 2-mercaptonicotinic acid (2-MNA). These thiomers were incorporated in a concentration of 0.3% (w/v) into SEDDS. The size distribution and the zeta potential of the emulsions were evaluated by dynamic light scattering. Mucoadhesive properties of thiomers-SEDDS spiked with FDA (fluorescein diacetate) were examined utilizing rheological measurement, permeation studies and in vitro residence time study on porcine mucosa. Cell viability tests were additionally performed. RESULTS: 734 ± 58 μmol L-Cysteine methyl ester and 562 ± 71 μmol 2-MNA could be attached per gram polymer of Pemulen TR-2. Emulsions exhibited a droplet size range between 180 and 270 nm. Blank SEDDS possessed a zeta potential value between -5.7 and -8.6 mV, whereas thiomers-SEDDS between -14.6 and -17.2 mV. Viscous modulus of thiomer and preactivated thiomer containing SEDDS-mucus mixture was 8-fold and 11-fold increased in comparison to reference. The amount of FDA permeated the mucus layer was 2-fold lower in case of thiomers-SEDDS compared to blank SEDDS. A prolonged residence time was observed for thiomers-SEDDS over 45 min. During cell viability studies no severe toxic effects were detected. CONCLUSION: The novel developed SEDDS with incorporated thiomers might be a promising tool for mucoadhesive oral drug delivery.
PURPOSE: The aim of the study was to create novel mucoadhesive drug delivery systems by incorporating amphiphilic hydrophobically modified, thiolated and preactivated polymers (preactivated thiomers) into self-emulsifying drug delivery systems (SEDDS). METHODS:L-Cysteine methyl ester was covalently attached to the polymeric backbone of Pemulen TR-2 and preactivated using 2-mercaptonicotinic acid (2-MNA). These thiomers were incorporated in a concentration of 0.3% (w/v) into SEDDS. The size distribution and the zeta potential of the emulsions were evaluated by dynamic light scattering. Mucoadhesive properties of thiomers-SEDDS spiked with FDA (fluorescein diacetate) were examined utilizing rheological measurement, permeation studies and in vitro residence time study on porcine mucosa. Cell viability tests were additionally performed. RESULTS: 734 ± 58 μmol L-Cysteine methyl ester and 562 ± 71 μmol 2-MNA could be attached per gram polymer of Pemulen TR-2. Emulsions exhibited a droplet size range between 180 and 270 nm. Blank SEDDS possessed a zeta potential value between -5.7 and -8.6 mV, whereas thiomers-SEDDS between -14.6 and -17.2 mV. Viscous modulus of thiomer and preactivated thiomer containing SEDDS-mucus mixture was 8-fold and 11-fold increased in comparison to reference. The amount of FDA permeated the mucus layer was 2-fold lower in case of thiomers-SEDDS compared to blank SEDDS. A prolonged residence time was observed for thiomers-SEDDS over 45 min. During cell viability studies no severe toxic effects were detected. CONCLUSION: The novel developed SEDDS with incorporated thiomers might be a promising tool for mucoadhesive oral drug delivery.
Entities:
Keywords:
mucoadhesive SEDDS; mucoadhesive drug delivery; nanocarrier; preactivated thiomer; self-emulsifying drug delivery systems
Authors: Janine Griesser; Gergely Hetényi; Michael Moser; Frédéric Demarne; Vincent Jannin; Andreas Bernkop-Schnürch Journal: Int J Pharm Date: 2017-02-07 Impact factor: 5.875
Authors: S Köllner; S Dünnhaupt; C Waldner; S Hauptstein; I Pereira de Sousa; A Bernkop-Schnürch Journal: Eur J Pharm Biopharm Date: 2015-01-17 Impact factor: 5.571
Authors: Guru R Valicherla; Kandarp M Dave; Anees A Syed; Mohammed Riyazuddin; Anand P Gupta; Akhilesh Singh; Kalyan Mitra; Dipak Datta; Jiaur R Gayen Journal: Sci Rep Date: 2016-05-31 Impact factor: 4.379
Authors: Rabia Arshad; Tanveer A Tabish; Maria Hassan Kiani; Ibrahim M Ibrahim; Gul Shahnaz; Abbas Rahdar; Misook Kang; Sadanand Pandey Journal: Nanomaterials (Basel) Date: 2021-04-22 Impact factor: 5.076
Authors: Nathalie Hock; Giuseppe Francesco Racaniello; Sam Aspinall; Nunzio Denora; Vitaliy V Khutoryanskiy; Andreas Bernkop-Schnürch Journal: Adv Sci (Weinh) Date: 2021-11-12 Impact factor: 16.806